Get answers for your health queries from top Doctors for FREE!

100% Privacy Protection

100% Privacy Protection

We maintain your privacy and data confidentiality.

Verified Doctors

Verified Doctors

All Doctors go through a stringent verification process.

Quick Response

Quick Response

All Doctors go through a stringent verification process.

Reduce Clinic Visits

Reduce Clinic Visits

Save your time and money from the hassle of visits.

  1. Home /
  2. Patient Stories /
  3. Nanavati Super Speciality Hospital Helps a Patient from Bang...

Nanavati Super Speciality Hospital Helps a Patient from Bangladesh in Her Breast Cancer Treatment

Follow Diya's inspiring breast cancer treatment journey from Bangladesh to Nanavati Max Superspeciality, aided by Clinicspots' support, as she receives targeted therapy, undergoes successful surgery, and achieves a cancer-free outcome.

By Namita Prasad

8th Aug '23

Table of Contents :

Patient Name: Diya

Treatment: Breast Cancer

Gender: Female

Country Origin: Bangladesh

Age: 57

Symptoms: Weight loss and breast pain and discharge from the nipple

Hospital: Nanavati Max Super Specialty Hospital

Doctor name: Dr. Muzammil Shaikh

 

Diya, a 57-year-old woman from Bangladesh, was presented with symptoms including weight loss, breast pain, and discharge from the nipple. After undergoing a biopsy in Bangladesh, she received the diagnosis of triple-negative breast cancer. The biopsy results indicated that her tumor was negative for Estrogen Receptor/Progesterone Receptor (ER/PR) and HER2.

During Diya's breast cancer treatment journey, she received valuable assistance from Clinicspots, a healthcare platform that connects patients with medical specialists and facilitates medical travel.

ClinicSpots referred Diya's case to Nanavati Max Superspeciality for further evaluation and treatment. Her biopsy block was reviewed at the hospital, where additional tests such as mammography, abdominal CT scan, and blood tests were conducted. These tests confirmed the triple-negative status of her breast cancer.

Read more to learn how the treatment was planned to provide the best treatment for Diya. 

Treatment Plan

Under the care of Dr. Sanjay Dudhar and Dr. Mozambil Shaikh (Medical Oncologist) Diya's treatment plan was devised. 

Given her triple-negative breast cancer, she was scheduled to receive targeted therapy in combination with chemotherapy as the initial treatment. approach. A total of six targeted therapy sessions, along with chemotherapy, were administered before her surgery.

Surgery and Post-Operative Outcome

After completing the targeted therapy and chemotherapy, Diya underwent surgery in January. The surgical procedure successfully removed the tumor, eliminating the need for radiation therapy. Following the surgery, Diya's histopathology report confirmed that she was completely cancer-free.

Continuing Treatment in Bangladesh, Diya returned to Bangladesh after her surgery and continued her treatment plan. She received the remaining targeted therapy sessions, which involved injections every 21 days. This treatment aimed to further support her recovery and prevent the recurrence of breast cancer.

 

Results

Once Diya completed her targeted therapy in Bangladesh, she returned to Nanavati Max Superspeciality for a follow-up evaluation. Her overall progress had been positive, as she had experienced weight gain, resumed normal eating habits, and exhibited no concerning symptoms. Regular follow-up appointments ensured her ongoing well-being and monitored her long-term recovery.

Diya and her family sought support from Clinicspots for treatment abroad. Clinicspots provided crucial information, facilitated coordination between healthcare teams, arranged appointments, managed medical records, and assisted with logistics.

Inquire about personalized treatment expenses. Contact us today for more information.

Note: We respect our patient's privacy, so the name has been changed to maintain confidentiality.

Breast Cancer Hospitals In Other Cities

Top Related Speciality Doctors In Other Cities